Targeted adjuvant therapy in non-small cell lung cancer: trick or treat?

L.E.L. Hendriks*, J. van Meerbeeck, J. Cadranel

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Article number2101637
Number of pages7
JournalEuropean Respiratory Journal
Volume58
Issue number4
DOIs
Publication statusPublished - 1 Oct 2021

Keywords

  • TYROSINE KINASE INHIBITORS
  • SURVIVAL ANALYSIS
  • PLUS CISPLATIN
  • EGFR
  • OSIMERTINIB
  • IMMUNOTHERAPY
  • CHEMOTHERAPY
  • VINORELBINE
  • BENEFIT
  • PD-L1

Cite this